deltatrials

Pulmonary disease, chronic obstructive Trials in Ste Foy, Canada

Conditions / Pulmonary disease, chronic obstructive / Ste Foy, Canada

Research into Pulmonary disease, chronic obstructive spans multiple therapeutic approaches and trial phases.

18 total trials for this combination

Showing top 10 of 18 trials

Trials

NCT ID Title Status Phase
NCT00662740 Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD) TERMINATED PHASE3
NCT01431287 Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) COMPLETED PHASE3
NCT01525615 A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD COMPLETED PHASE3
NCT02296138 Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease. COMPLETED PHASE3
NCT00463567 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) COMPLETED PHASE2/PHASE3
NCT00452400 Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD. COMPLETED PHASE2
NCT00500318 A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) COMPLETED PHASE3
NCT00523991 Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD). COMPLETED PHASE4
NCT01533935 Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients. COMPLETED PHASE3
NCT00152984 Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma COMPLETED PHASE4

Related Pages